Skip to main content
. 2012 Nov;85(Spec Iss 1):S18–S27. doi: 10.1259/bjr/15403217

Table 2. Risk groups for localised prostate cancer.

Parameter Low risk Intermediate risk High risk
Tumour stage T1–T2a and T2b–T2c or T3a or
Gleason score 2–6 and 7 or 8–10 or
Pre-treatment PSA ≤10 ng ml–1 10–20 ng ml–1 >20 ng ml–1

PSA, prostate-specific antigen.